Related Experiment Video
Updated: Jun 11, 2026
14:32
Deacetylation Assays to Unravel the Interplay between Sirtuins (SIRT2) and Specific Protein-substrates
Published on: February 27, 2016
A role for SIRT1 in the hypoxic response
Scott F Leiser1, Matt Kaeberlein
1Department of Pathology, University of Washington, Seattle, WA 98195, USA.
Molecular Cell
|July 13, 2010
Summary
Sirtuin 1 (SIRT1) deacetylates hypoxia-inducible factor 1-alpha (HIF-1alpha), regulating its response to low oxygen. This reveals a new SIRT1 function and links HIF in aging to sirtuin enzymes.
Area of Science:
- Biochemistry
- Molecular Biology
- Cellular Metabolism
Background:
- The protein deacetylase SIRT1 (silent mating type information regulation 2 homolog 1) is a key regulator of cellular metabolism and stress responses.
- Hypoxia-inducible factor 1-alpha (HIF-1alpha) is a transcription factor crucial for cellular adaptation to low oxygen conditions (hypoxia).
Discussion:
- Lim et al. demonstrate that SIRT1 directly interacts with and deacetylates HIF-1alpha.
- This deacetylation by SIRT1 modulates the stability and transcriptional activity of HIF-1alpha.
- The findings suggest a novel regulatory mechanism for HIF-1alpha function.
Key Insights:
- SIRT1 deacetylates HIF-1alpha, impacting its response to hypoxic conditions.
- This regulation influences cellular adaptation pathways under low oxygen.
- Establishes a functional link between sirtuin enzymes and HIF-mediated responses.
Outlook:
- Further research may elucidate the precise role of SIRT1-mediated HIF-1alpha regulation in aging and age-related diseases.
- This discovery opens avenues for therapeutic strategies targeting the SIRT1-HIF axis.
Related Concept Videos
01:23Hypoxia
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:31Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...